rheumatologyadvisor13h
FDA Approves Tocilizumab Biosimilar Avtozma
The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.
PharmiWeb1d
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
Healio4d
FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.
Medical experts investigating Lucy Letby baby deaths say 'we did not find any murders' amid claims evidence used to convict nurse is not supported by facts…
Follow live updates as experts present new evidence in the case of child serial killer Lucy Letby who was jailed for killing ...
technologynetworks2d
Low Doses of Oral Ketamine Can Reduce PTSD Symptoms, Study Suggests
A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in ...
Weakness, trouble in movement, repeated injections: Recovered patients talk about theit brush with GBS
Although the disease has left him shaken and he still experiences some weakness, Pawar is now back home with his family and is trying to get back to his normal life.
PipelineReview.com4d
U.S. FDA approves Celltrion’s AVTOZMA® (tocilizumab-anoh), a biosimilar to ACTEMRA®
JERSEY CITY, NJ, USA I January 30, 2025 I Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA® (CT-P47, ...
ALS News Today1d
Radicava delays time to certain ALS disease progression milestones
In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...
Contract Pharma4d
FDA Approves Celltrion’s Biosimilar to ACTEMRA
The U.S. Food and Drug Administration (FDA) has approved Celltrion’s AVTOZMA (CT-P47, tocilizumab-anoh) in both an ...
Low-dose oral ketamine shows promise in treating PTSD symptoms
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...